NCT00480792View on ClinicalTrials.gov

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

September 30, 2012

Conditions
HIV Infections
Interventions
BIOLOGICAL

GenHevac B Pasteur

Intra-muscular injection 20 microgramme Intramuscular use at M0, M1, M6

BIOLOGICAL

GenHevac B Pasteur

Intra-muscular injection 40 microgramme intramuscular use at M0, M1,M2, M6

BIOLOGICAL

GenHevac B Pasteur

GenHevac-B 4 microgramme Intradermal use at M0, M1, M2, M6

Trial Locations (1)

75014

Hopital Cochin CIC de vaccinologie, Paris

Sponsors

Collaborators (1)

MCM Vaccines B.V.
All Listed Sponsors
collaborator

MCM Vaccines B.V.

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT00480792 - Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients | Biotech Hunter | Biotech Hunter